Literature DB >> 26673643

Expanded HTA: Enhancing Fairness and Legitimacy.

Norman Daniels1, Thalia Porteny2, Julian Urritia2.   

Abstract

All societies face the need to make judgments about what interventions (both public health and personal medical) to provide to their populations under reasonable resource constraints. Their decisions should be informed by good evidence and arguments from health technology assessment (HTA). But if HTA restricts itself to evaluations of safety, efficacy, and cost-effectiveness, it risks being viewed as insufficient to guide health decision-makers; if it addresses other issues, such as budget impact, equity, and financial protection, it may be accused of overreaching. But the risk of overreaching can be reduced by embedding HTA in a fair, deliberative process that meets the conditions required by accountability for reasonableness.
© 2016 by Kerman University of Medical Sciences.

Entities:  

Keywords:  Accountability for Reasonableness; Budget Impact; Cost-effectiveness; Efficacy; Equity; Fairness; Financial Protection; Health Technology Assessment (HTA); Legitimacy; Safety

Mesh:

Year:  2015        PMID: 26673643      PMCID: PMC4676965          DOI: 10.15171/ijhpm.2015.187

Source DB:  PubMed          Journal:  Int J Health Policy Manag        ISSN: 2322-5939


  5 in total

1.  The development of health technology assessment.

Authors:  David Banta
Journal:  Health Policy       Date:  2003-02       Impact factor: 2.980

2.  Toward a procedure for integrating moral issues in health technology assessment.

Authors:  Bjørn Hofmann
Journal:  Int J Technol Assess Health Care       Date:  2005       Impact factor: 2.188

Review 3.  Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine.

Authors:  J E Siegel; M C Weinstein; L B Russell; M R Gold
Journal:  JAMA       Date:  1996 Oct 23-30       Impact factor: 56.272

4.  Making fair choices on the path to universal health coverage.

Authors:  Trygve Ottersen; Ole F Norheim
Journal:  Bull World Health Organ       Date:  2014-06-01       Impact factor: 9.408

5.  Why not integrate ethics in HTA: identification and assessment of the reasons.

Authors:  Bjørn Hofmann
Journal:  GMS Health Technol Assess       Date:  2014-11-26
  5 in total
  21 in total

1.  Expanded HTA, Legitimacy and Independence Comment on "Expanded HTA: Enhancing Fairness and Legitimacy".

Authors:  Keith Syrett
Journal:  Int J Health Policy Manag       Date:  2016-09-01

2.  HTA - Algorithm or Process? Comment on "Expanded HTA: Enhancing Fairness and Legitimacy".

Authors:  Anthony J Culyer
Journal:  Int J Health Policy Manag       Date:  2016-08-01

3.  Beyond the Black Box Approach to Ethics! Comment on "Expanded HTA: Enhancing Fairness and Legitimacy".

Authors:  Lars Sandman; Erik Gustavsson
Journal:  Int J Health Policy Manag       Date:  2016-04-20

4.  The Need for Global Application of the Accountability for Reasonableness Approach to Support Sustainable Outcomes Comment on "Expanded HTA: Enhancing Fairness and Legitimacy".

Authors:  Jens Byskov; Stephen Oswald Maluka; Bruno Marchal; Elizabeth H Shayo; Salome Bukachi; Oseph M Zulu; Erik Blas; Charles Michelo; Benedict Ndawi; Anna-Karin Hurtig
Journal:  Int J Health Policy Manag       Date:  2017-02-01

Review 5.  Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes.

Authors:  Samantha Roberts; Eleanor Barry; Dawn Craig; Mara Airoldi; Gwyn Bevan; Trisha Greenhalgh
Journal:  BMJ Open       Date:  2017-11-15       Impact factor: 2.692

6.  Equity in HTA: what doesn't get measured, gets marginalised.

Authors:  Richard Cookson; Andrew J Mirelman
Journal:  Isr J Health Policy Res       Date:  2017-07-10

7.  Three Case Studies in Making Fair Choices on the Path to Universal Health Coverage.

Authors:  Alex Voorhoeve; Tessa T T Edejer; Lydia Kapiriri; Ole F Norheim; James Snowden; Olivier Basenya; Dorjsuren Bayarsaikhan; Ikram Chentaf; Nir Eyal; Amanda Folsom; Rozita Halina Tun Hussein; Cristian Morales; Florian Ostmann; Trygve Ottersen; Phusit Prakongsai; Carla Saenz; Karima Saleh; Angkana Sommanustweechai; Daniel Wikler; Afisah Zakariah
Journal:  Health Hum Rights       Date:  2016-12

8.  Using Cost-Effectiveness Analysis to Address Health Equity Concerns.

Authors:  Richard Cookson; Andrew J Mirelman; Susan Griffin; Miqdad Asaria; Bryony Dawkins; Ole Frithjof Norheim; Stéphane Verguet; Anthony J Culyer
Journal:  Value Health       Date:  2017-02       Impact factor: 5.725

9.  Ethics in HTA: Examining the "Need for Expansion".

Authors:  Payam Abrishami; Wija Oortwijn; Bjørn Hofmann
Journal:  Int J Health Policy Manag       Date:  2017-10-01

10.  MCDA from a health economics perspective: opportunities and pitfalls of extending economic evaluation to incorporate broader outcomes.

Authors:  Mark Jit
Journal:  Cost Eff Resour Alloc       Date:  2018-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.